Literature DB >> 17566573

NGAL (neutrophil gelatinase-associated lipocalin) and cystatin C: are they good predictors of contrast nephropathy after percutaneous coronary interventions in patients with stable angina and normal serum creatinine?

H Bachorzewska-Gajewska, J Malyszko, E Sitniewska, J S Malyszko, B Poniatowski, K Pawlak, S Dobrzycki.   

Abstract

The aim of the study was to assess whether NGAL and cystatin C could predict contrast-induced nephropathy in non-diabetic patients (n=60, mean age 60+/-11 years) with normal serum creatinine undergoing elective PCI. We found a significant rise in serum NGAL after 2, 4 and 8 h, and in urinary NGAL after 4, 8 and 24 h after PCI. Cystatin C rose significantly 8 and 24 h after the procedure. Prevalence of CIN was 10%. We found 90% sensitivity and 74% specificity of serum and 76% sensitivity and 80% specificity of urinary NGAL increase. NGAL may represent a sensitive early biomarkers of renal impairment after PCI.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17566573     DOI: 10.1016/j.ijcard.2007.04.048

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  20 in total

1.  Neutrophil gelatinase-associated lipocalin in the diagnosis of type 1 cardio-renal syndrome in the general ward.

Authors:  Margarida Alvelos; Rodrigo Pimentel; Elika Pinho; André Gomes; Patricia Lourenço; Maria José Teles; Pedro Almeida; João Tiago Guimarães; Paulo Bettencourt
Journal:  Clin J Am Soc Nephrol       Date:  2010-11-29       Impact factor: 8.237

2.  Potential Role of Allopurinol in Preventing Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention: A Randomized Placebo-Controlled Trial.

Authors:  Zahra Ghelich Khan; Azita Hajhossein Talasaz; Hamidreza Pourhosseini; Kianoush Hosseini; Mohammad Javad Alemzadeh Ansari; Arash Jalali
Journal:  Clin Drug Investig       Date:  2017-09       Impact factor: 2.859

3.  Serum neutrophil gelatinase-associated lipocalin (NGAL) in predicting worsening renal function in acute decompensated heart failure.

Authors:  Arash Aghel; Kevin Shrestha; Wilfried Mullens; Allen Borowski; W H Wilson Tang
Journal:  J Card Fail       Date:  2009-08-21       Impact factor: 5.712

4.  Neutrophil Gelatinase-Associated Lipocalin as a Marker for Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention: A Prospective Observational Analysis.

Authors:  Ankit Kumar Sahu; Pravin K Goel; Roopali Khanna; Sudeep Kumar; Aditya Kapoor; Satyendra Tewari; Naveen Garg
Journal:  Indian J Nephrol       Date:  2022-03-23

5.  Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of cyclosporine nephrotoxicity?

Authors:  Anna Wasilewska; Walentyna Zoch-Zwierz; Katarzyna Taranta-Janusz; Joanna Michaluk-Skutnik
Journal:  Pediatr Nephrol       Date:  2010-05       Impact factor: 3.714

6.  Accuracy of plasma neutrophil gelatinase-associated lipocalin in the early diagnosis of contrast-induced acute kidney injury in critical illness.

Authors:  Xavier Valette; Benoit Savary; Marie Nowoczyn; Cédric Daubin; Véronique Pottier; Nicolas Terzi; Amélie Seguin; Sabine Fradin; Pierre Charbonneau; Jean-Luc Hanouz; Damien du Cheyron
Journal:  Intensive Care Med       Date:  2013-01-30       Impact factor: 17.440

7.  Comparison of Different Hydration Strategies in Patients with Very Low-Risk Profiles of Contrast-Induced Nephropathy.

Authors:  Shuai Miao; Zheng-Kai Xue; Ya-Ru Zhang; Hao Zhang; Jing-Jin Che; Tong Liu; Hua-Yue Tao; Guangping Li; Kang-Yin Chen
Journal:  Med Sci Monit       Date:  2021-04-30

8.  The role of neutrophil-gelatinase-associated lipocalin in early diagnosis of contrast nephropathy.

Authors:  M R Khatami; M R P Sabbagh; N Nikravan; Z Khazaeipour; M A Boroumand; S Sadeghian; B Davoudi
Journal:  Indian J Nephrol       Date:  2015 Sep-Oct

9.  Early trends in cystatin C and outcomes in patients with cirrhosis and acute kidney injury.

Authors:  Justin M Belcher; Arun J Sanyal; Guadalupe Garcia-Tsao; Naheed Ansari; Steven G Coca; Michael G Shlipak; Chirag R Parikh
Journal:  Int J Nephrol       Date:  2014-03-18

10.  Serum lipocalin-2 levels positively correlate with coronary artery disease and metabolic syndrome.

Authors:  Jie Ni; Xiaojing Ma; Mi Zhou; Xiaoping Pan; Junling Tang; Yaping Hao; Zhigang Lu; Meifang Gao; Yuqian Bao; Weiping Jia
Journal:  Cardiovasc Diabetol       Date:  2013-12-21       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.